New insights into the pathobiology of Down syndrome - Hyaluronan synthase-2 overexpression is regulated by collagen VI α2 chain

FEBS Journal

Volumn 280, Issue 10, 2013, Pages 2418-2430

  Karousou, Evgenia ^a   Stachtea, Xanthi ^b   Moretto, Paola ^a   Viola, Manuela ^a   Vigetti, Davide ^a   D'Angelo, Maria Luisa ^a   Raio, Luigi ^c   Ghezzi, Fabio ^a   Pallotti, Francesco ^a   De Luca, Giancarlo ^a   Karamanos, Nikos K ^b   Passi, Alberto ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b UNIVERSITY OF PATRAS   (Greece)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

collagen type VI; Down syndrome; hyaluronan; hyaluronan synthase; Wharton's jelly

Indexed keywords

COLLAGEN TYPE 6; COLLAGEN VI ALPHA1; COLLAGEN VI ALPHA2; HYALURONAN SYNTHASE 2; HYALURONIC ACID; SYNTHETASE; UNCLASSIFIED DRUG;

ARTICLE; CARBOHYDRATE SYNTHESIS; COL6A2 GENE; CONTROLLED STUDY; DOWN REGULATION; DOWN SYNDROME; FETUS; GENE DOSAGE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; GESTATIONAL AGE; HAS2 GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; SKIN FIBROBLAST; UMBILICAL CORD;

CELL NUCLEUS; CELLS, CULTURED; COLLAGEN TYPE VI; CULTURE MEDIA, CONDITIONED; DOWN SYNDROME; FETUS; FIBROBLASTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE SILENCING; GESTATIONAL AGE; GLUCURONOSYLTRANSFERASE; HUMANS; HYALURONIC ACID; RNA, SMALL INTERFERING; TRANSFECTION; UMBILICAL CORD;

EID: 84877688590     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12220     Document Type: Article

References (55)

1. Megarbane A, Ravel A, Mircher C, Sturtz F, Grattau Y, Rethore MO, Delabar JM, &, Mobley WC, (2009) The 50th anniversary of the discovery of trisomy 21: the past, present, and future of research and treatment of Down syndrome. Genet Med 11, 611-616.
2. Barlow GM, Chen XN, Shi ZY, Lyons GE, Kurnit DM, Celle L, Spinner NB, Zackai E, Pettenati MJ, Van Riper AJ, et al,. (2001) Down syndrome congenital heart disease: a narrowed region and a candidate gene. Genet Med 3, 91-101.
3. Gardiner C, Lanigan B, &, O'Keefe M, (2008) Postcataract surgery outcome in a series of infants and children with Down syndrome. Br J Ophthalmol 92, 1112-1116.
4. Wegiel J, Gong CX, &, Hwang YW, (2011) The role of DYRK1A in neurodegenerative diseases. FEBS J 278, 236-245.
5. Kusters MA, Verstegen RH, &, de Vries E, (2011) Down syndrome: is it really characterized by precocious immunosenescence? Aging Dis 2, 538-545.
6. Davies GE, Howard CM, Farrer MJ, Coleman MM, Bennett LB, Cullen LM, Wyse RK, Burn J, Williamson R, &, Kessling AM, (1995) Genetic variation in the COL6A1 region is associated with congenital heart defects in trisomy 21 (Down's syndrome). Ann Hum Genet 59, 253-269.
7. Grossman TR, Gamliel A, Wessells RJ, Taghli-Lamallem O, Jepsen K, Ocorr K, Korenberg JR, Peterson KL, Rosenfeld MG, Bodmer R, et al,. (2011) Over-expression of DSCAM and COL6A2 cooperatively generates congenital heart defects. PLoS Genet 7, e1002344.
8. Bohlandt S, von Kaisenberg CS, Wewetzer K, Christ B, Nicolaides KH, &, Brand-Saberi B, (2000) Hyaluronan in the nuchal skin of chromosomally abnormal fetuses. Hum Reprod 15, 1155-1158. (Pubitemid 30251317)
9. von Kaisenberg CS, Prols F, Nicolaides KH, Maass N, Meinhold-Heerlein I, &, Brand-Saberi B, (2003) Glycosaminoglycans and proteoglycans in the skin of aneuploid fetuses with increased nuchal translucency. Hum Reprod 18, 2544-2561. (Pubitemid 37536619)
10. Quarello E, Guimiot F, Moalic JM, Shnoneau M, Ville Y, &, Delezoide AL, (2007) Quantitative evaluation of collagen type VI and SOD gene expression in the nuchal skin of human fetuses with trisomy 21. Prenat Diagn 27, 926-931. (Pubitemid 47597920)
11. Raio L, Ghezzi F, Cromi A, Cereda E, &, Passi A, (2004) Sonographic morphology and hyaluronan content of umbilical cords of healthy and Down syndrome fetuses in early gestation. Early Hum Dev 77, 1-12. (Pubitemid 38534443)
12. Raio L, Cromi A, Ghezzi F, Passi A, Karousou E, Viola M, Vigetti D, De Luca G, &, Bolis P, (2005) Hyaluronan content of Wharton's jelly in healthy and Down syndrome fetuses. Matrix Biol 24, 166-174. (Pubitemid 40693638)
13. Casini P, Nardi I, &, Ori M, (2012) Hyaluronan is required for cranial neural crest cells migration and craniofacial development. Dev Dyn 241, 294-302.
14. Schraufstatter IU, Serobyan N, Loring J, &, Khaldoyanidi SK, (2010) Hyaluronan is required for generation of hematopoietic cells during differentiation of human embryonic stem cells. J Stem Cells 5, 9-21.
15. Li L, Asteriou T, Bernert B, Heldin CH, &, Heldin P, (2007) Growth factor regulation of hyaluronan synthesis and degradation in human dermal fibroblasts: importance of hyaluronan for the mitogenic response of PDGF-BB. Biochem J 404, 327-336. (Pubitemid 46849604)
16. Afratis N, Gialeli C, Nikitovic D, Tsegenidis T, Karousou E, Theocharis AD, Pavao MS, Tzanakakis GN, &, Karamanos NK, (2012) Glycosaminoglycans: key players in cancer cell biology and treatment. FEBS J 279, 1177-1197.
17. Karousou E, Kamiryo M, Skandalis SS, Ruusala A, Asteriou T, Passi A, Yamashita H, Hellman U, Heldin CH, &, Heldin P, (2010) The activity of hyaluronan synthase 2 is regulated by dimerization and ubiquitination. J Biol Chem 285, 23647-23654.
18. Vigetti D, Clerici M, Deleonibus S, Karousou E, Viola M, Moretto P, Heldin P, Hascall VC, De Luca G, &, Passi A, (2011) Hyaluronan synthesis is inhibited by adenosine monophosphate-activated protein kinase through the regulation of HAS2 activity in human aortic smooth muscle cells. J Biol Chem 286, 7917-7924.
19. Vigetti D, Deleonibus S, Moretto P, Karousou E, Viola M, Bartolini B, Hascall VC, Tammi M, De Luca G, &, Passi A, (2012) Role of UDP-N-acetylglucosamine (GlcNAc) and O-GlcNAcylation of hyaluronan synthase 2 in the control of chondroitin sulfate and hyaluronan synthesis. J Biol Chem 287, 35544-35555.
20. von der Mark H, Aumailley M, Wick G, Fleischmajer R, &, Timpl R, (1984) Immunochemistry, genuine size and tissue localization of collagen VI. Eur J Biochem 142, 493-502. (Pubitemid 14054376)
21. Jander R, Rauterberg J, &, Glanville RW, (1983) Further characterization of the three polypeptide chains of bovine and human short-chain collagen (intima collagen). Eur J Biochem 133, 39-46. (Pubitemid 13056915)
22. Weil D, Mattei MG, Passage E, N'Guyen VC, Pribula-Conway D, Mann K, Deutzmann R, Timpl R, &, Chu ML, (1988) Cloning and chromosomal localization of human genes encoding the three chains of type VI collagen. Am J Hum Genet 42, 435-445.
23. Ball S, Bella J, Kielty C, &, Shuttleworth A, (2003) Structural basis of type VI collagen dimer formation. J Biol Chem 278, 15326-15332. (Pubitemid 36799871)
24. Colombatti A, Mucignat MT, &, Bonaldo P, (1995) Secretion and matrix assembly of recombinant type VI collagen. J Biol Chem 270, 13105-13111.
25. Heinegard D, (2009) Proteoglycans and more-from molecules to biology. Int J Exp Pathol 90, 575-586.
26. Levine JM, &, Nishiyama A, (1996) The NG2 chondroitin sulfate proteoglycan: a multifunctional proteoglycan associated with immature cells. Perspect Dev Neurobiol 3, 245-259. (Pubitemid 126839134)
27. Burg MA, Tillet E, Timpl R, &, Stallcup WB, (1996) Binding of the NG2 proteoglycan to type VI collagen and other extracellular matrix molecules. J Biol Chem 271, 26110-26116. (Pubitemid 26347453)
28. Fitzgerald J, Rich C, Zhou FH, &, Hansen U, (2008) Three novel collagen VI chains, alpha4(VI), alpha5(VI), and alpha6(VI). J Biol Chem 283, 20170-20180.
29. Wagener R, Gara SK, Kobbe B, Paulsson M, &, Zaucke F, (2009) The knee osteoarthritis susceptibility locus DVWA on chromosome 3p24.3 is the 5′ part of the split COL6A4 gene. Matrix Biol 28, 307-310.
30. Nakajima M, Miyamoto Y, &, Ikegawa S, (2011) Cloning and characterization of the osteoarthritis-associated gene DVWA. J Bone Miner Metab 29, 300-308.
31. Mcdevitt CA, Marcelino J, &, Tucker L, (1991) Interaction of intact type-Vi collagen with hyaluronan. FEBS Lett 294, 167-170.
32. Engvall E, Hessle H, &, Klier G, (1986) Molecular assembly, secretion, and matrix deposition of type VI collagen. J Cell Biol 102, 703-710. (Pubitemid 16013128)
33. Franc S, Rousseau JC, Garrone R, van der Rest M, &, Moradi-Ameli M, (1998) Microfibrillar composition of umbilical cord matrix: characterization of fibrillin, collagen VI and intact collagen V. Placenta 19, 95-104. (Pubitemid 28112067)
34. Romanowicz L, &, Jaworski S, (2002) Collagen of umbilical cord vein and its alterations in pre-eclampsia. Acta Biochim Pol 49, 451-458. (Pubitemid 135686792)
35. von Kaisenberg CS, Brand-Saberi B, Christ B, Vallian S, Farzaneh F, &, Nicolaides KH, (1998) Collagen type VI gene expression in the skin of trisomy 21 fetuses. Obstet Gynecol 91, 319-323. (Pubitemid 28119828)
36. Hatamochi A, Aumailley M, Mauch C, Chu ML, Timpl R, &, Krieg T, (1989) Regulation of collagen VI expression in fibroblasts. Effects of cell density, cell-matrix interactions, and chemical transformation. J Biol Chem 264, 3494-3499. (Pubitemid 19063408)
37. Gittenberger-de Groot AC, Bartram U, Oosthoek PW, Bartelings MM, Hogers B, Poelmann RE, Jongewaard IN, &, Klewer SE, (2003) Collagen type VI expression during cardiac development and in human fetuses with trisomy 21. Anat Rec A Discov Mol Cell Evol Biol 275, 1109-1116. (Pubitemid 37486787)
38. Heckmann M, Aumailley M, Hatamochi A, Chu ML, Timpl R, &, Krieg T, (1989) Down-regulation of alpha 3(VI) chain expression by gamma-interferon decreases synthesis and deposition of collagen type VI. Eur J Biochem 182, 719-726. (Pubitemid 19169967)
39. Dziadek M, Darling P, Bakker M, Overall M, Zhang RZ, Pan TC, Tillet E, Timpl R, &, Chu ML, (1996) Deposition of collagen VI in the extracellular matrix during mouse embryogenesis correlates with expression of the alpha 3(VI) subunit gene. Exp Cell Res 226, 302-315. (Pubitemid 26260555)
40. Engidawork E, Baiic N, Fountoulakis M, Dierssen M, Greber-Platzer S, &, Lubec G, (2001) Beta-amyloid precursor protein, ETS-2 and collagen alpha 1 (VI) chain precursor, encoded on chromosome 21, are not overexpressed in fetal Down syndrome: further evidence against gene dosage effect. J Neural Transm Suppl 61, 335-346. (Pubitemid 38085095)
41. Lamande SR, Sigalas E, Pan TC, Chu ML, Dziadek M, Timpl R, &, Bateman JR, (1998) The role of the alpha 3(VI) chain in collagen VI assembly-expression of an alpha 3(VI) chain lacking N-terminal modules N10-N7 restores collagen VI assembly, secretion, and matrix deposition in an alpha 3(VI)-deficient cell line. J Biol Chem 273, 7423-7430. (Pubitemid 28152764)
42. Kimura M, Cao X, Skurnick J, Cody M, Soteropoulos P, &, Aviv A, (2005) Proliferation dynamics in cultured skin fibroblasts from Down syndrome subjects. Free Radic Biol Med 39, 374-380. (Pubitemid 40910194)
43. Colombatti A, &, Bonaldo P, (1987) Biosynthesis of chick type VI collagen. II. Processing and secretion in fibroblasts and smooth muscle cells. J Biol Chem 262, 14461-14466.
44. Kadner A, Zund G, Maurus C, Breymann C, Yakarisik S, Kadner G, Turina M, &, Hoerstrup SP, (2004) Human umbilical cord cells for cardiovascular tissue engineering: a comparative study. Eur J Cardiothorac Surg 25, 635-641. (Pubitemid 38376081)
45. Heimli H, Kahler H, Endresen MJ, Henriksen T, &, Lyberg T, (1997) A new method for isolation of smooth muscle cells from human umbilical cord arteries. Scand J Clin Lab Invest 57, 21-29. (Pubitemid 27160882)
46. Draheim CC, Geijer JR, &, Dengel DR, (2010) Comparison of intima-media thickness of the carotid artery and cardiovascular disease risk factors in adults with versus without the Down syndrome. Am J Cardiol 106, 1512-1516.
47. Hyett J, Moscoso G, &, Nicolaides K, (1997) Abnormalities of the heart and great arteries in first trimester chromosomally abnormal fetuses. Am J Med Genet 69, 207-216. (Pubitemid 27113745)
48. Cheng IH, Lin YC, Hwang E, Huang HT, Chang WH, Liu YL, &, Chao CY, (2011) Collagen VI protects against neuronal apoptosis elicited by ultraviolet irradiation via an Akt/phosphatidylinositol 3-kinase signaling pathway. Neuroscience 183, 178-188.
49. Tammi RH, Passi AG, Rilla K, Karousou E, Vigetti D, Makkonen K, &, Tammi MI, (2011) Transcriptional and post-translational regulation of hyaluronan synthesis. FEBS J 278, 1419-1428.
50. Vigetti D, Genasetti A, Karousou E, Viola M, Clerici M, Bartolini B, Moretto P, De Luca G, Hascall VC, &, Passi A, (2009) Modulation of hyaluronan synthase activity in cellular membrane fractions. J Biol Chem 284, 30684-30694.
51. Bovolenta M, Neri M, Martoni E, Urciuolo A, Sabatelli P, Fabris M, Grumati P, Mercuri E, Bertini E, Merlini L, et al,. (2010) Identification of a deep intronic mutation in the COL6A2 gene by a novel custom oligonucleotide CGH array designed to explore allelic and genetic heterogeneity in collagen VI-related myopathies. BMC Med Genet 11, 44-56.
52. Li Y, Toole BP, Dealy CN, &, Kosher RA, (2007) Hyaluronan in limb morphogenesis. Dev Biol 305, 411-420. (Pubitemid 46686606)
53. Stempfle N, Huten Y, Fredouille C, Brisse H, &, Nessmann C, (1999) Skeletal abnormalities in fetuses with Down's syndrome: a radiographic post-mortem study. Pediatr Radiol 29, 682-688. (Pubitemid 29408304)
54. Karousou EG, Porta G, De Luca G, &, Passi A, (2004) Analysis of fluorophore-labelled hyaluronan and chondroitin sulfate disaccharides in biological samples. J Pharm Biomed Anal 34, 791-795. (Pubitemid 38264559)
55. Mitropoulou TN, Lamari F, Syrokou A, Hjerpe A, &, Karamanos NK, (2001) Identification of oligomeric domains within dermatan sulfate chains using differential enzymic treatments, derivatization with 2-aminoacridone and capillary electrophoresis. Electrophoresis 22, 2458-2463. (Pubitemid 32725553)